. Retention time (tR), HRMS n data, molecular formula and identification of taxifolin and its metabolites in rats by HPLC-DAD-ESI-IT-TOF-MS n . Abbreviations: N means that the fragment ions of a metabolite are not obtained, and its corresponding extracted ion chromatograms in negative ion mode is shown in Figure S4 -S11. Abbreviations: B1, Antioxidant; B2, Anti-inflammatory; B3, Antitumor; B4, Cardioprotective; B5, Antidiabetic; B6, Antimicrobial; B7, Antiviral; B8, Hepatoprotective; B9, Prevention of Alzheimer disease; B10, Immunoregulatory; B11, Xanthine oxidase inhibitor; B12, Neuroprotective Table S3 . The reported targets of taxifolin and its bioactive metabolites.
Target Name Parent and Metabolites
Nrf2 TAX [68] , M80 [39] , M70 [69] , M104 [70] β-amyloid (Aβ) peptides TAX [71] , M70 [71] , M76 [72] PI3-K phosphoinositide 3-kinase (PI3K) TAX [73] , M80 [74] , M70 [75] MEK1 M70 [76] , M80 [74] EGF receptor (EGFR) TAX [73] , M70 [77] heme oxygenase-1 (HO-1), M70 [78] , M104 [70] microRNA-155 M70 [79] , M80 [79] TBK1-kinase M70 [80] , M104 [80] Figure S2 . Proposed fragmentation pathways of taxifolin in negative ion detection mode mass spectra. Figure S3 . Proposed fragmentation pathways of M160 in negative ion detection mode; (A) MS n spectra of M160 (B) fragmentation pathways, characteristic fragment ions, and proposed structure. 
